Please be informed that EXOMIDE Bio-Engineered Exosomes will now be identified by newly updated packaging artwork, reflecting our enhanced exosome specification.
Important Confirmation
- The sleeve artwork update has been made for regulatory registration and compliance communication purposes in the European and U.S. markets.
- The artwork update itself does not indicate any compromise in product quality, formulation integrity, or manufacturing control.
- EXOMIDE Skin Ampoule from Lot No. GEA120 has been enhanced with increased exosome concentration to improve treatment value in line with market needs.
- EXOMIDE Scalp Ampoule from Lot No. GESA111 has an updated sleeve artwork, while product quality and specifications remain consistent.
- Partners and clinics are kindly requested to inform relevant team members and customers accordingly to avoid confusion during product receipt and use.